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ABSTRACT
We have analyzed the structure of Ig K chain genes in B cell lines
derived from a human individual who cannot synthesize anyK chains, and whose
Igs all contain X chains (1). We have characterized secondary DNA
recombination events at two K alleles which have undergone misaligned V-J
recombinations. One such secondary recombination has joined the flanking
sequences of a VK and a JK2 gene segment as if it were the reciprocal product
of a V-JK2 recombination, and resulted in the displacement of the recombined
VJK1 gene segments from the CK locus. The non-rearranged form of the VK
fragment which had recombined with the JK2 flank was cloned. Nucleotide
sequencing of this fragment identified a VK gene that differed by at least
38% from all previously sequenced human VK genes. The other V-JK segment
analyzed has undergone a secondary recombination at a different site from
that described above, at a site within the intervening sequence between the JK
and CK gene segments, similar to the location of secondary recombinations
which have occurred in X + B cell lines from mice and humans (2,3). These
results prove that multiple recombinations can occur at one JK-CK locus.
INTRODUCTION
Although recombination of immunoglobulin (Ig) K chain V and J genes
results in deletion of the DNA between the recombined gene segments, VK-JK
joining may not generally occur by an intrachromatid deletion because DNA
fragments located 5' to the JK genes, which should be deleted during
intrachromatid deletion, are frequently preserved within K-expressing
hybridomas, lymphocytes and plasmacytomas (4,5). In addition, DNA fragments
which appear to be reciprocal products of VK-JK recombination, i.e.
recombined flanking regions of VK and JK gene segments, which would result
from V-J recombination occurring by interchromatid recombination (sister
chromatid exchange) or by intrachromatid inversion have been found in
plasmacytomas, hybridomas and lymphomas (6-8). However, an alternative
explanation for the lack of deletion of DNA sequences located 5' to the JK
gene segments and for the presence of reciprocal products of VK-JK
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recombination is re-integration of sequences excised during intrachromatid
deletion (8).
I9 CK genes are frequently deleted from B cell lines which express Ig X
chains (9-11). Data have been presented suggesting that in mice a particular
DNA sequence from the chromosome bearing the X chain genes may be frequently
involved in recombination events, apparently with a particular sequence
within the intervening sequence (IVS) between the JK and CK gene segments,
effecting the deletion of CK genes (2). Recently it has been shown that
deletion of CK genes from human X+ cell lines is also accompanied by a
recombination at an analogous position within the IVS between the JK and CK
segments (3).
While investigating the structure of Ig K chain genes in B cell lines
derived from a hunan individual who cannot synthesize any K chains and whose
Igs all contain K chains (1), we discovered and characterized a recombination
event which resulted in separation of the CK gene from a misaligned V-JK
recombination product. This event joined the 3' flank of a VK gene with the
5' flank of JK2, and was the reciprocal product of a VK-JK2 recombination.
Unlike other examples of reciprocal products of VK-JK recombination which
have been characterized (6-8), this recombination product is located 3' to a
recombined VK-JK1 gene segment. In the other cases reported, recombined
flanking sequences (usually from JK1) were found unlinked to any recombined
V-JK segments.
The VK gene whose flanking sequences had recombined with the JK2 flank
was cloned and sequenced. It was found to encode a VK domain which defines a
new human VK subgroup as it does not belong to any of the four known human VK
subgroups (12-17). This new VK gene is a member of a single-gene family.
A second misaligned recombined V-JK allele was also cloned, and shown to
have also undergone a secondary recombination event, at a different site from
that utilized in the first fragment, and which may have resulted in deletion
of the CK gene segment from the chromosome. Although the recombination
junction has not been sequenced, it resides at the 5' end of the IVS between
the JK and CK gene segments at a position analogous to that utilized in
recombinations which may have resulted in the deletion of CK genes from mouse
and human X+ B cell lines (2,3).
MATERIALS AND METHODS
Establishment of
_lymphoblastoid cell lines (LCLs).
Sterile heparinized venous blood was obtained from a normal human adult
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and from the K-deficient patient. Leukocytes isolated according to the
method of Boyum (18) were exposed to the B95-8 leukocyte transforming strain
of Epstein-Barr virus (EBV) at a multiplicity of infection such that 80-100%
0
of the wells contained transformed cells (19). LCLs were maintained at 37 C
in RPMI-1640 supplemented with 17% fetal bovine serum, 1 mM glutamine, and
antibiotics in an atmosphere of 5% CO2.
Two of the LCLs from the patient (P1 and P2 in Fig. 1) were tested and
found to express X chains and X mRNA, and no K chains or K mRNA (A. Solomon,
Univ. of Tennessee, and M. Cooper, Univ. of Alabama, personal communications;
J.S. unpublished data).
Cloning of LCLs.
0.3, 1 or 10 cells were plated into individual wells of 96 well plates,
containing irradiated feeder layers of human fibroblasts. More than 20
clones from the patient's LCL and 10 clones from the normal LCL were
obtained. Although the frequency of growing cells in the wells indicated
that the clones originated from single cells, all 20 clones from the
patient's LCL, and all 10 clones from the normal LCL were identical (by
Southern blotting analyses of their J genes), but not with each other.
Apparently the predominant clone in each culture had been isolated. A
karyotype analysis was performed on the cloned LCL derived from the patient
by Dr. P. Szabo, Cornell University, NYC. The cells contained two
normal-appearing chromosome 2's ( K gene-bearing chromosome).
Genomic DNA isolation, restriction enzyme digestion, gel electrophoresis, DNA
blotting.
These procedures were performed as described (20,21).
Nucleic acid annealing.
Annealing mixtures contained 50% deionized formamide, 0.02% bovine serum
albumin, 0.02% polyvinyl pyrrolidine, 0.02% Ficoll, 50 jug E.coli DNA/ml, 900
mM NaCl, 90 mM sodium citrate, 0.06 mM disodium EDTA. Annealing was
performed at 42 C. The blots were washed as described (21). To renove the
annealed probe so that the blots could be re-used, the blots were incubated
0
in annealing mixture without the labeled probe at 68 C for 30 min.
Hybridization probes.
Probes were nick-translated fragments isolated from plasmids or x phage,
except as noted. The VK probe was a 558 bp PstI fragment isolated from
HK101/80, encoding a germline VK(subgroup 1) gene segment (12, given by T.
Rabbitts). The JK, IVS, and CK probes were fragments isolated from a
recombinant x phage containing the germline JK-CK gene segment (22,23, given
3497
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by P. Leder). The regions used as probes are indicated above the restriction
map of the normal germline JK-CK gene segment in Fig. 2A. The region
encoding the 1.8 kb probe derived from the recombinant phage EVJK2 is
indicated beneath the restriction map of EVJK2 (Fig. 2B). A single-stranded
hybridization probe complementary to the coding strand of the VK gene present
in EV15 was prepared (24) by priming DNA synthesis with a primer (PL
Biochemicals) that annealed 5' to the insert in recombinant M13 phage which
contained the 572 bp PstI-PvuII fragment encoding the EV15 VK gene (Fig. 2C).
Isolation of recombinant X bacteriophage from the patient's LCLs.
a. EVJK2. DNA was prepared from an uncloned LCL (P3) which had been
frozen soon after transfornation, as it has been reported that normal X- B
cells are more likely to contain JK and CK genes than are X+ B cell lines,
suggesting that JK-CK gene segments may be deleted from cells during growth
in vitro (10,25). Bam fragments, the size of the rearranged JK fragment in
this LCL (7-12 kb) (Fig. 1B, lane P3), were purified by agarose gel
electrophoresis and ligated to Bam arms of the X vector, L47.1 (26). Three
recombinant phage containing the identical insert were isolated by screening6
2 x 10 plaques with the JK probe.
b. EVJK11 and EV15. A LCL which had been passaged extensively (P1)6
provided the DNA used to prepare a MboI library containing 1 x 10 PFU of
14-21 kb fragments cloned in Charon 30 (27). By screening this library with
the JK probe and with the 1.8 kb probe from EVJK2, we obtained 2 recombinant
phage, EVJK11 and EV15, respectively.
Cloning into M13 phage vectors and DNA sequencing.
Restriction fragments were ligated into various M13 mp vectors, and
cloned by transformation of JM103 by the CaCl2 procedure (28,29). Recombinant
phage were grown in JM103, and single-stranded phage DNA was isolated by
slight modifications of published procedures (28,29). DNA sequencing by the
dideoxynucleotide chain termination procedure was performed as described
(28-30), except reactions were incubated at 37 C. The Klenow fragment of DNA
polyinerase I was purchased from Boehringer-Mannheim, New England Nuclear
Corp. or BRL with approximately equivalent results. 8% polyacrylanide gels
(31), either 36 or 90 cm in length, were used. Gels were soaked 5-10 min. in
10% acetic acid, dried on a gel dryer, and exposed to X-ray film.
RESULTS
Rearranged JK but no CK genes were detected in LCLs from the patient.
In DNA blotting experiments, the Vk, JK. and CK genes appeared normal in
3498
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Fig. 1. Blot of BamHI-digested genomic DNA from LCLs and from nomal
placenta annealed with Ig Kchain probes. Lanes contained 10Mug of cellular
DNA from: Plac. - nomal placenta; C1-C2, LCLs from nomal human; P1-P5, LCLs
from K-deficient human. P4 was a cloned cell line; P1-P3 and P5 were
uncl oned.
The sizes (in kb) of X bacteriophage DNA digested with HindIII,
electrophoresed in a parallel lane, are indicated on the left. Blots were
annealed with the probes indicated below each panel. The DNA regions present
in the probes are indicated in Fig. 2.
The fragment indicated by &6 in B, lane P2, and by a tiny dot in C, lane
P2, was cloned into the recombinant X phage EVJK2. The arrow in B, lane P3,
indicates the other JK fragment that also annealed with the 1.8 kb probe in
LCLs from the patient. Thel in B, lane P1, indicates the Bam fragment a
portion of which was cloned in EVJK11 (from a MboI library). The * in C,
lane P1, indicates the 8.1 kb Bam fragment cloned in EV15.
non Ig-producing cells from the K-deficient patient. However, when the
nucleotide sequence of the CK genes from both alleles was detemined, it was
found that in each of the CK coding regions a single different point mutation
had occurred, resulting in the replacement of highly conserved amino acids
responsible for maintaining the secondary structure of the C region with
different amino acids. Thus, neither of the CK genes appeared to encode a
functional K chain (32). To examine the effect of these mutations on the
structure of the K genes in B cells from the patient, B lymphoblastoid cell
lines (LCLs) were produced by transformation of the patient's blood
leukocytes with Epstein-Bar virus (19). Southern blotting experiments on DNA
from a few cell lines from the patient, including one cloned cell line,
3499
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Fig. 2. Restriction maps of cloned DNA segments encoding Ig K genes.
A. Map of normal germline JK- CK allele (21), which is also present in
non Ig-producing cells from the K-deficient individual. Above the map are
indicated the DNA segments used as JK, IVS, and C Kprobes.
B,C. EVJK2 contains a misaligned recombined VJK1 segment located 5' to
the site of recombination with the EV15 fragment. The maps of EVJK2 and EV15
are identical 3' to the vertical arrow, where the 3' flank of the EV15 VK
gene has recombined with the 5' flank of JK2.
D. The EVJK11 fragment contains a misaligned recombined VJK3 segment
located 5' to the site of recombination (at arrow) with an unidentified DNA
segment.
Maps of cloned DNA segments were obtained utilizing the technique of "in
gel" hybridization (47).
Code for restriction enzymes: B, BamHI; E, EcoRI; H, HindIII; K, KpflI;
Pv, PvuII; P, PstI; S, SacI (SstI); Xb, XbaI; X, XhoI.
indicated that the LCLs contained rearranged JK fragments which did not
anneal with the CK probe, and that no germline Jc-CK gene segments were
present (Fig. 1A,B). The probes utilized are indicated on the map in Fig.
2A. The absence of CK but not of JK gene segments can be expected from the
fact that the patient's B cells express Xchains (1; M. Cooper and A.
Solomon, personal communications), since X+ B cells have more frequently
deleted CK than JK gene segments (2,3,9,11).
Analysis of an aberrantly recombined V-JK fragment from the patient.
To characterize the recombination events which produced rearranged JK
fragments lacking associated CK gene segments, one such fragment (the 7.6 kb
BamHI fragment indicated with an arrow in Fig. 1B, lane P3) was cloned into
Bam arms of the , bacteriophage vector, L47.1 (26). The cloned fragment
(EVJK2) hybridized with nick-translated probes for human VK (HK101) (12) and
JK gene segments, but not with probes for the IVS between JK and CK or for
3500
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Fig. 3. Sequencing strategy for EVJK2 and EV15 fragments. Restriction
maps of a portion of the germl ine JK locus (A) aligned with EVJK2 (B) to
illustrate the site of recombination in EVJK2 between the 5' border of J'2
and the 3' border of the VKgene in EV15 (C).
Each arrow indicates direction and length of an independent sequencing
reaction, usually performed on different M13 clones.
Although no fragment which overlapped the PstI site located 5' to the
leader peptide of the EV15 VK gene was sequenced, restriction enzyme mapping
data agreed completely with the sequence. For example, the 57 bp HaeIII
fragment containing this PstI site was observed.
the CK gene segment (22). The map of the EVJK2 fragment, with the location
of the V and J gene segments indicated, is given in Fig. 2B. The map showed
that 3' to the recombined V-J gene segments an additional recombination had
occurred, resulting in the displacement of the CK gene segment from the
recombined V-J segments.
The nucleotide sequence of the region in EVJK2 which hybridized with the
VK and JK probes was determined by cloning restriction fragments into M13
phage vectors (28,33), and sequencing by the dideoxynucleotide procedure
(28-30), according to the strategy indicated by the arrows under the
restriction map (Fig. 3B). The sequence (Fig. 4) indicated that the 5' end
of the Bam fragment encoded a VK protein 95% homologous to the amino acid
sequence of the subgroup 4 VK protein, LEN (13). However, the VK gene has
recombined with the JK1 gene segment incorrectly, resulting in a frameshift
mutation, which altered the amino acid sequence encoded by the JK1 gene
segment. Although the frameshift mutation did not create a nonsense mutation
in framework 3 (FR 3), the amino acid sequence differs at each amino acid
position from the normal JKJ-encoded sequence. It is not known whether such
a K chain could interact effectively with heavy (H) chains to form a
functional antibody molecule. The nucleotide sequence of the region 3' to
JK1 was identical to the sequence of the normal germline JK-CK segment (23),
3501
Nucleic Acids Research
BanHI
OOATCCAATTATCTOCTOACTTATAATACTACTAOAAAOCAAATTTAAAT0ACATATTTC
10 20 30 40 50 60
AATTATATCTOAOACAOCOTOTATAAOTTTATOTATAATCATTOTCCATTACTGACTACA
70 80 90 100 110 120
-4 +1 FR 1
9 A Y OlD I V N T Q S P D S L A V S L 0
9GTGCCTACOGOO ACATCOTOATOACCCAOTCTCCAGACTCCCTOOCTOTOTCTCT000C
130 140 150 160 170 180
231 24 CDI 1
E R A T I N C N A S Q S V L Y S 3 11 K
GOAOGOACCACCATCAACTGCAATGCCAOCCAGAOTOTTTTATACAGCTCCAACAATAAG
190 200 210 220 230 240
34T 35 FR 2 49I 50
1 Y L A W Y Q Q K P 0 Q P P K L L I Y w
AACTACTTAOCTTGOTACCAOCAOAAACCAGOACAOCCTCCTAAGCTGCTCATTTACTGO
250 260 270 280 290 300
CDR 2 56 1 57 FR 3
A S T R ES G V P D R F S G S SO T D
OCATCTACCCGG0AATCCOOOGTCCCTGACCOATTCA0TO0OCACOGOTCTOGOACAOAT
310 320 330 300 350 360
Pstl 88 189
F T L T I S3S L Q A E D V A V Y T C Q Q
TTCACTCTCACCATCAOCAOCCTGCA0GCTGAAGATGTGGCAGTTTATTACToTCAOCAA
370 380 390 400 010 420
CDR 3 95 JKI
T y S T I G R S A K G P R W K S N
TATTATAGTACTCTCC TGG ACOTTCOOCCAAGGG ACCAAGO TGG AAATCJAvA TGAOT
430 40 150 460 47 0 480
AOAATTTAAACTTTOCTTCCTCAGTTOTCTGTOTCTTCTGTTCCCTGTGTCTATOAAOTG
090 500 510 520 530 510
6
ATCTATAAOCTGACTCTGCAATCAGCCTCTGATATCCTTCAGOG AAAAOATAAAOATAAO
550 560 570 580 590 600
XhoI GT
TCTOTAGTCAAACTCGAGAATTGATTGCACATTTTCTTTGAAGAGCAAOCAAGATTCATG
610 620 630 600 650 660
ACATTGGGTGAGAATAACTTGTCTAAOTAATAOCTTCAOAAATOTCCTGOOOAACATAACA
670 680 690 700 710 720
TGTTCTOG ACA AGOCCTTOO TCAATTGTCAOAAAGOO AATTTTTGTGkAGOAGGO AAOTT
730 740 750 760 770 780
Recombipation site
AAOGAGGACOATTGTCACAGT TACACCCTOTCA1AAAC TCCAAOTTCTCTCAOT
790 L800 810 820 830 840
Pvull
0G0 ATTOCCTCAOCTGCTGCTGAAAATGTTCAGAATGTGGAACTGOGTOOCC
850 860 870 880 890
Fig. 4. Sequence of EVJK2: recombined VJc1 segments and site of
recombination with EV15. The site of recombination with the 3' flank of the
VK gene in EV15 occurred after nucleotide 796, precisely at the 3' end of the
heptamer recognition sequence 5' to JK2. The heptamer and nonamer
recognition sequences are boxed.
A frameshift mutation has occurred at the VJK1 junction, putting the JK1
gene out of correct reading frame. The protein sequence encoded is
indicated. At nucleotide positions 538 and 573 the sequence disagrees with
ref. 23, but agrees with ref. 14. At position 550 the EVJK2 sequence
disagrees with the published sequences (14,23). Their determination is given
above the EVJK2 sequence. At positions 659, 660, 708 only one sequence has
been published (23) and it disagrees with EVJK2. RNA splice sites are
indicated by: / Anino acids which differ from the subgroup 4 protein, LEN,
are indicated with asterisks.
except for 6 nucleotides at scattered positions (at two of these positions
the sequence agreed with the sequence of the normal JK1 flank published by
Klobeck et al., 14), until the site of the second recombination on this
3502
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allele at the 5' border of JK2. The sequence of the recombined DNA appeared
identical with the 3' flanking regions of hunan VK genes, as it contained the
conserved heptamer and nonamer of the V-J joining sequences, separated by a
12 bp spacer.
Cloning and sequencing of the VK gene whose flanking sequences are in EVJK2.
To detemine whether the DNA which had recombined with the JK2 segment
in the patient's LCLs encoded a VK gene, the non-rearranged fonm (8.1 kb Bam
fragment) of this DNA segment was cloned from the LCL derived from the
patient analyzed in Fig. 1C, lane P1 (8.1 kb fragment is marked with a
diamond). The 1.8 kb EcoRI-Bam fragment from EVJK2 (Fig. 2B) was used as a
probe to screen the recombinant X bacteriophage. The map of the fragment
obtained, EV15 (Fig. 2C), is identical to the map of the DNA segment which
anneals with the 1.8 kb probe in non Ig-producing cells, e.g. placenta (data
not shown). The maps of EV15 and EVJK2 in the region located 3' to the
recombination site (indicated by the arrows) are identical (Fig. 2B,C), and
the sequences of the 340 bp SstI-HindIII fragments located 1.4 kb 3' to the
site of recombination are identical in EVJK2 and EV15 (data not shown). The
nucleotide sequence of a 854 bp region in EV15 containing the recombination
site was detemined, according to the strategy indicated in Fig. 3C, and is
presented in Fig. 5.
By a computer aided search, the region of EV15 located immediately 5' to
the recombination site was found to contain a VK gene which is very different
from all previously identified VK genes (12-17). Although the EV15 VK gene
contains no obvious mutations which would prevent it from producing a
functional K chain, none of the large number of Kchains and KcDNAs which have
been sequenced (12-17) appear to be encoded by this VK gene. The protein
sequence encoded by EV15 is most closely related to subgroup 3 Wcproteins,
52% homologous to the most closely related member of this group (encoded by
the cDNA clone, NG9 (15), and 45-49% homologous to subgroup 1,2 and 4 VK
proteins (12,13). However, the nucleotide sequence of the EV15 V domain is
more related to the subgroup 1 VK gene, HK102, than to NG9 (62% as compared
to 55% homology). At 33% of the amino acid residues the sequence of the EV15
VK protein differs from all the amino acids at that position in published
sequences of subgroup 3 proteins. The most common amino acid present at
these positions in subgroup 3 VK proteins is indicated above the EV15 amino
acid sequence in Fig. 5 (13). Because the differences between the EV15
sequence and other VK sequences are so great, it appears unlikely that the
EV15 VK sequence was derived by somatic mutation of a VK gene belonging to
3503
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580 600
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D T Q Q K P a 3 A A I Q ATOATAT0AAqr00TACCAACAOAAACCA0AOAAOcToCTATTTTcATTTTcA4TC AOC
620 640 660
CDR 2 56 FR 3
S R A T D G
T T L V P 0 I P P R8 3 O 3 G0 0 T D P
TACTACTCTCOTTCCS OAATCCCACCTCOATTCAOTOOCAOCOOOTATOGAACAOATTT
680 700 720
S R L P F v 88 yT L T I 8I I 2 22 D A A T y FC Q HTACCCTCACAATTAATAACATAOAATCTOAOOATOCTOCATATTACTTCTG TACAACA
740 760 780
CDR 3 s
D N f P
TOATAATTTCCCTC C&CjSCTACACCCTO CAAAACETCAOTTCTCTCAOTOO
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PvuII
OATTOCCTCAOCTO
850
Fig. 5. Nucleotide sequence of the EV15 VK gene and site of
recombination with EVJK2. The recombination with the 5' flank of JK2 to
produce EVJK2 occurred after nucleotide 795, precisely at the 5' border of
the heptamer located 3' to the VK gene segment. The heptamer and nonamer
recognition sequences are within rectangles.
Stretches of 8 or more nucleotides which are identical with those of
HK102 (subgroup 1) (12) are underlined. Such identities occur at the
conserved octanucleotide (oc) (positions 194-201) (35,36), within the leader
peptide (although the identical sequence in HK102 is located at the splice
donor of the leader!), within the IVS in the leader, and within FRs 1 and 2.
Although the nucleotide sequence of the EV15 VK gene is more homologous
to HK102 than to NG9 (62% vs. 55%), the amino acid sequence is more
homologous to NG9 than HK102 (52% vs. 45%) (12,15). At the positions where
the amino acid sequence differs from all subgroup 3 proteins the most common
amino acid in the subgroup 3 sequences (13) is given above the EV15-encoded
sequence.
3504
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one of the known subgroups.
Although the sequence of the EV15 VK gene differs greatly from that of
other human VK genes, the overall features of the gene are in accord with
those of other VK genes. The signal peptide is 20 amino acids in length,
rather than the more common 22, but it is very hydrophobic and has a
leucine-rich region, which is typical of Ig V signal sequences. Furthermore,
Pecht et al. (17) have also identified a human VK gene with a signal peptide
20 amino acids in length. The VK domain encoded by the EV15 VK gene is of
the appropriate length (95 amino acid residues), and many of the conserved
amino acids of VK proteins are present (13) (including the invariant
cysteines, positions 23 and 88, and tryptophan, position 35, required to form
a stable intradomain disulfide bond) (34). Both the donor and acceptor RNA
splice sites within the codon for asp (D) at the -4 position within the
signal peptide differ by one nucleotide from the canonical sequences (35):
the donor site, at nucleotide position 352, is TG/GT instead of AG/GT, and
the acceptor, at nucleotide position 497, is CAG/A instead of CAG/G. But, as
these sequences are present in functional splice donors and acceptors (35),
presumably this IVS can be correctly spliced. Furthermore, the conserved
octanucleotide, the 5' end of which is located approximately 100 bp 5' to the
initiator met of all VK and Vx genes (36,37) is located 110 nucleotides 5' to
the initiator met (positions 194-201).
A comparison of the nucleotide sequences of EV15 and EVJK2 locates the
precise site of recombination between the EV15 fragment and the 5' flank of
JK2 which produced the EVJK2 fragment. The sequence of the region located 3'
to nucleotide 795 in the EV15 sequence (Fig. 5) is identical to the sequence
of EVJK2 3' to nucleotide 796 (Fig. 4), indicating that the site of
recombination is precisely at the 5' end of the heptamer at the 3' flank of
the EV15 VK gene, and at the 3' end of the heptamer located at the 5' border
of JK2. All other such reciprocal recombination products which have been
described have also been derived by recombinations which occurred precisely
at the 5' end of the V and 3' end of the JK heptamers (6-8), or precisely at
the 5' end of the D and 3' end of the JH heptamers (38).
The EV15 VK gene is a member of a single gene family.
Since the sequence of the EV15 VK gene differs so greatly from all other
known hiznan VK sequences, it appears to not be a member of any of the
previously identified VK subgroups. To determine if the EV15 VK gene is
related to other genes in the human genome, as would be expected if it were a
member of a typical VK gene family, the 572 bp PstI-PvuII fragment encoding
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FDIC f Mg-Fig. 6. Blot of DNAs from non Ig producing
tissues annealed with the EV15 V gene. The lanes
contained BamHI-digested DNA from: Pla, normal
placenta; F, father of patient; M, mother of
patient; EV, patient. The blot was annealed with
the 572 bp PstI-PvuII fragment encoding the VK
domain of EV15.
R kb-
the EV15 VK region was annealed to a blot containing DNA from normal placenta
and from blood leukocytes from the K-deficient individual and his two
parents. One fragment was detected in all four of the DNAs digested with
either Bam (Fig. 6) or EcoRI (not shown). The fact that the EV15 VK gene is
not a member of a multi-gene family further indicates that the differences
between the EV15 VK gene and other VK genes are not due to somatic mutation,
because if EV15 were derived by extensive somatic mutation from a member of
the previously identified VK subgroups, it should anneal to other members of
the subgroup and it should not anneal so strongly to a single DNA fragment
from non Ig-producing cells. The existence of a V gene which is not a member
of a group of related genes has been described before, as the VK gene
expressed in the mouse myeloma, MOPC 167, is also the only member of a VK
group (39,40).
The EV15 VK gene is frequently rearranged in LCLs from both the normal and K
-deficient individual.
Since the EV15 VK gene has not been found to be expressed we decided to
determine how commonly it was rearranged in LCLs from the K-deficient and
normal humans. To search for possible reciprocal recombination products, as
was found in EVJK2, the 1.8 kb EcoRI-Bam fragment from the region 3' to the
site of recombination (Fig. 2B) was used to probe blots of DNA from normal
placenta and from LCLs from the patient and from a normal individual. The
1.8 kb probe annealed with a unique Bam fragment, 8.1 kb in length in
placenta DNA (Fig. 1C, lane Plac.), which was rearranged in one of two LCLs
from the normal individual (Fig. 1C, lane C2) and in three LCLs from the K
-deficient individual (lanes P1-P3). In one uncloned (P5) and one cloned
(P4) LCL derived from the patient no fragments were detected by the 1.8 kb
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probe. In the two control LCLs none of the three rearranged JK fragments
co-migrated with fragments that annealed with the 1.8 kb probe (Fig.lB,C:
lanes C1,C2), whereas in three LCLs from the patient, two of the five
rearranged JK fragments co-migrated with fragments that annealed with the 1.8
kb probe (using two different enzymes). The JK Bam fragments from the
patient's LCLs which also annealed with the 1.8 kb probe are indicated by
arrows in lanes P2 and P3 (Fig. 1B). If the EV15 flanking sequences had
recombined with the Ji1 flanking sequences in the three other rearrangements,
the JK probe would not detect this fragment, since it only detects 14
nucleotides 5' to the JK1 flank (23). Although one of the control LCLs (lane
C2) contained DNA from cells which were mostly X+ (by RNA blotting
experiments; data not shown), the sample number is too low to conclude that
the recombination between this fragment and JK segments was specific to the
patient' s LCLs.
To determine which chromosome encoded the EV15 VK gene, a blot of DNAs
from human-mouse somatic cell hybrids which contained partial complements of
the human chromosome set (41) was probed with the 1.8 kb probe. The fragment
was localized to the short arm of chromosome 2, in the sub-region containing
the K chain genes (42,43) (data not shown).
Cloning of a second aberrant V-J fragment from the K-deficient individual.
A second example of a recombined V-JK allele which also lacked a CK gene
was cloned from a LCL derived from the patient by screening the MboI DNA
library described above with the JK probe. The fragment which was cloned
(EVJK11) was derived from the 8 kb Bam fragment present in the DNA analyzed
7 IOO0bp XS
x enn
A. Germline O l
B. EVJK 11
Jai Js12 J,A3 JM14 JL5 s
-
-afc 5e* 0.CL &-C,) CU) o- CO)
In ± 3 *4 *5 I
-s _
__k r-
Fig. 7. Allgnment of EVJK11 and the gernline JKsegments; sequencing
strategy for Kll. The site of recombination which deleted the CK gene
from EVJKll occurred within the SstI-HindIII fragment located 3' to the JK
gene segments, within the region indicated by the bracket (determined by
partial nucleotide sequencing and by restriction enzyme mapping; data not
shown).
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LEADER
-20
Sstl N E T P A Q
GAGCTCTGGGGAGGAACTGCTCAGTTAGGACCCAGAGGGAACCATGGAAACCCCAGCOCA
10 20 30 40 50 60
-5
L L F L L L L W L PGCTTCTCTTCCTCCTGCTACTCTGGCTCCCAqk TGAGGGG AACATGOG ATGG TTTTGCAT
70 80 90 100 110 120
GTCAGTGAAAACCCTCTCAAGTCCTGTTACCTGGCAACTCTGCTGAATCAATACAATAAT
130 140 150 160 170 180
TAAAGCTCAATATAAAGCTCAATTCTGGCTCTTCTGGGAGACAGTGGGTTTGATTTAGAT
190 200 210 220 230 2110
FR 1
V P S +1
P T T C E I V LTACATCGG TGACTTTTCTATTTTATTTCCAATCTCA ATACCACCGGAGAAATTGTGTTG
250 260 270 ' 300
G 23 R
T Q S P A T L S L S P O E R A T L S cI 0
ACGCAGTCTCCAGCCACCCTGTCTTTGTCTCCAGOOGAAAGAOCCACCCTCTCCTGCOGO
360
CDR 1 FR 2
34 G Q
A S Q S V S S S Y L A W Q Q K P R L A
GCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTCGCCTGGCG
KpnI 420
CDR 2
49 G T 56
P R L L I YID A S S R A T I P D R F SCCCAGGCTCCTCATCTATGATGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGT
480
FR 2
A
G S G S O T D F T L T I S R L E P E D F
GGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTT540
CDR 3 JK3
88 M G
A V Y Y C Q Q Y G S S R P A L G P K W I
GCAGTGTATTACTGTCAGCAGTATGGTAGCTCACGC CGGCCCTGCGACCAAAGTGGATA
600
A
S N
TCAAA TAAGTACATCTGTCTCAATTATTCGTGAGATTTTAGTG/ 610 620 630 640
Fig. 8. Sequence of the recombined VJ,c3 segment of EVJK11. The EVJK11
VK gene is a member of subgroup 3. The amino acids which differ from the
most closely related member of subgroup 3, NG9, are given above the EVJK11
amino acid sequence (15). At the site of recombination between the V and
JK3 gene segments, indicated by I , 8 nucleotides from the 5' end of JK3 have
been deleted, creating a frameshift mutation.
in Fig. 1B, lane P1 (marked with a triangle). The recombination which
separated the C gene from this V-J gene segment occurred at a different site
from that in EVJK2, within the IVS located 3' to the JK genes (indicated by
the arrow above Fig. 2D), and did not involve the EV15 fragment (data not
shown). We have not determined the source of the DNA which has recombined
with the IVS in EVJK11. If it is derived from the region located 3' to the CK
gene, this recombination would result in deletion of the CK gene segment from
the chromosome. By probing Southern blots of LCLs with the 0.9 kb SstI
fragment which includes the site of recombination, we have found that this
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fragment is commonly rearranged in LCLs from the K-deficient and from the
normal human (data not shown).
The nucleotide sequence of the region encoding the recombined V-J gene
segment was detennined according to the strategy given in Fig. 7. The
sequence demonstrated that the EVJK11 fragment contained a subgroup 3 VK gene
which had recombined with the JK3 gene segment (Fig. 8). As in EVJK2, the
recombination was aberrant, resulting in a deletion of at least 8 nucleotides
from the 5' end of JK3 and a frameshift so that the JK3 coding triplets were
out of reading frame, but again, no termination codon was created in the JK3
segment. Although the amino acid sequence of the resulting FR3 sequence
differs greatly from the normal sequence encoded by JK3, we do not know if
this would prevent the formation of a functional K chain. The JK3 gene
segment did not contain any other nucleotides which differed from the
published germline sequence (23).
DISCUSSION
Different types of recombination events can result in displacement of a
recombined V-JK gene segment from the CK locus.
Although the two recombination events described above, resulting in
separation of CK genes from recombined V-JK gene segments occurred in B cell
lines derived from a K-deficient individual, we do not know if these
recombinations are causally related to the mutations within the CK genes of
this K-deficient individual. Both of the V-JKsegments whose associated C,
genes had been deleted had undergone an incorrect V-J recombination,
resulting in VK proteins with unusual FR4 regions. Since no K chains with
such altered FR4 regions have been previously reported, it appears likely
that such K chains would not be able to associate effectively into antibody
molecules. Thus, the recombinations which resulted in removal of the
recombined V-J segments from the CK locus may have been activated by the
misaligned V-J recombination or by the mutated CK genes.
The recombination events that generated the EVJK2 and EVJK11 fragments
would have resulted in the separation of a recombined V-J segment from the K
transcription activator (44-46) and the CK gene. Two possible pathways for
the generation of EVJK2 are diagrammed in Fig. 9. Since the LCLs from which
the EVJK2 fragment was cloned did not contain any CK genes, an additional
recombination event at this allele would be required to delete the CK gene.
Alternatively, if the EV15 VK gene were located 3' to the CK gene,
interchromatid recombination would have resulted in deletion of the CK gene.
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A. Sister Chromatid Exchange
EVJK2
VI JI X 4Js C _ V,+
V2 \V J bJ4 J5 C
B Inversion
A A A J2J3J4J5 C
_~~~_44 U
2. v1 J4J C
EVJK2
Fig. 9. Diagram of recombination events which could produce the EVJK2
fragment. The EVJK2 fragment is indicated by brackets above the top line in
A and bel ow the bottom line in B.
A. Generation of EVJK2 by sister chromatid exchange (interchromatid
recombination) subsequent to Vl-Jl recombination. The order of recombination
could have been reversed, i.e. joining of the VK and JK2 flanking sequences
could have occurred prior to the V-JK1 recombination. However, if
recombinations occurred in this order, the reciprocal fragment bearing a JK1
segment would be separated from the CK gene and the K enhancer, and this
conceivably could eliminate the recombinatorial activity of this locus. An
additional recombination would be required to delete the CKgene unless the
EV15 Wz gene were located 3' to the CK gene.
B. Generation of EVJK2 by inversion. (1) Production of a recombined
V2-J1 fragment. (2) A second inversion event forms the recombined V3-J2
fragment and simultaneously produces the V2-J1 fragment (EVJK2) separate from
the CK gene, although still linked on the same chromosome. An additional
recombination would be required to delete the CK gene segment.
Data have been presented suggesting that CK genes are frequently deleted from
mouse and human A+ cell lines by recombination between a specific sequence
within the IVS between the JK and CK gene segments and a specific DNA
sequence (RS) originating from the region 3' to the CK genes (2,3). Although
it was not determined whether the RS DNA did indeed originate from 3' to the
CK gene, Durdick et al. (2) did find that it originated from the chromosome
encoding the K chain genes. It is possible, albeit unlikely, that the
recombination events these authors studied separated the V-Jc gene segment
from the CK gene segment, but did not actually result in deletion of the CK
gene from the chromosome. One of the recombination events which resulted in
displacement of a recombined V-JK segment from a CK gene in an LCL from the K
- deficient human (EVJK11) occurred at a site located near the 5' end of the
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IVS between the JK and CK gene segments, as did the recombinations studied by
Durdick et al. (2) and Siminovitch et al. (3). We have not determined
whether the DNA which has recombined with the VJ segment in EVJK11 originated
from the K chain chromosome.
Generation of the EVJK2 fragment.
The existence of DNA fragments integrated into the genome which appear
to be reciprocal products of VK-JK recombination is consistent with VK-JK
recombination occurring by interchromatid recombination, by intrachromatid
inversion (7), or by re-insertion of deleted DNA segments produced by
intrachromatid recombination (8). This is also true for the EVJK2 fragment.
The recombined V and J flanking regions located 3' to a recombined VJO1 gene
segment could have been produced by interchromatid recombination (Fig. 9A),
or by inversion if only some of the VK genes are inverted with respect to the
J genes in gemline DNA or if the second VJ recombination event utilized VK
genes located 5' to the region inverted during the first recombination event
(Fig. 9B). Finally, the recombined V and J flanks in EVJK2 could have been
derived by re-insertion of deleted DNA (not shown) if the excised DNA
included the recombined VJO1 gene segment, in addition to the recombined
flanking sequences, because the sequence between Jl1 and JK2 is essentially
identical to the normal gemline sequence, showing no evidence of
recombination. It is also possible that VKand JO1 sequences present in
excised DNA recombined prior to reinsertion of an excised fragment, perhaps
simply because V and J flanking sequences are recombinogenic.
The structure of the EVJK2 fragment proves that more than one V-J
recombination event can occur at one JK-CK allele, as has been previously
hypothesized (5). Two events were required to produce the recombined V-JK1
gene segments and the recombined V-JK2 flanking sequences; presumably a third
event (perhaps of the type which occurred in EVJK11) resulted in deletion of
the CK gene from the chromosome.
It is attractive to postulate that recombinations causing the
displacement of the recombined V-J segments from the K enhancer and CK gene
segment would have the function of allowing replacement of a non-functional
V-J segment with another recombined V-J fragment which, perhaps, will be
functional, i.e. able to encode a K chain which can effectively recombine
with the H chain synthesized in that cell. Since in the K -deficient human
no K gene can be functional, recombination events at the K locus apparently
continue, until the CK genes are deleted. Since recombination events which
may have deleted the CK gene from x-producing cell lines occurred at a
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heptamer identical with the heptamer present in V-J recombination signals,
the deletion of the CK gene segment may also involve the V-J recombination
machinery (2,3).
A new hunan W gene identified.
The finding of a human VK gene which does not belong to any of the four
known human VK subgroups and which has never been found to be expressed was
surprising because significant portions of more than 85 expressed VK domains
have been sequenced and they all belong to one of the four subgroups (12-17).
Furthermore, by using the 1.8 kb fragment from EVJK2, which corresponds to
the region located 3' to the EV15 V gene, to probe blots of LCL DNA, we found
that this fragment was rearranged in, or deleted from, one of the two LCLs
examined from a normal human and in all of the LCLs from theK-deficient
individual (Fig. 1C). Although this VK gene is frequently rearranged in the
LCLs we have examined, we do not know whether it is ever functionally
rearranged. To begin to understand the function of this VK gene it will be
important to examine its structure in B cells from a normal human and to
determine if it is transcribed into Kchain mRNA in these cells. To shed
light on why it is so frequently rearranged in the LCLs we studied, it will
be important to determine where it is located relative to other Ig VK gene
segments and to the CK gene segment.
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